Anbok L. Lee

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 59 publications

Dental prosthesis needs among breast cancer survivors: a Korean nationwide cross-sectional study with subgroup analysis by menopausal status at diagnosis.

Dental prosthesis needs among breast cancer survivors: a Korean nationwide cross-sectional study with subgroup analysis by menopausal status at diagnosis.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: June 18, 2025

Training of Radiology Residents in Korea.

Training of Radiology Residents in Korea.

Journal: Korean journal of radiology

Published: November 10, 2024

Application of Metabolic Biomarkers in Breast Cancer: A Literature Review.

Application of Metabolic Biomarkers in Breast Cancer: A Literature Review.

Journal: Annals of laboratory medicine

Published: September 08, 2024

Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis.

Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis.

Journal: PloS one

Published: May 03, 2024

An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.

An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer.

Journal: Breast (Edinburgh, Scotland)

Published: August 02, 2023

Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.

Breast density reduction as a predictor for prognosis in premenopausal women with estrogen receptor-positive breast cancer: an exploratory analysis of the updated ASTRRA study.

Journal: International journal of surgery (London, England)

Published: July 05, 2023

Navigating the microbial community in the trachea-oropharynx of breast cancer patients with or without neoadjuvant chemotherapy (NAC) via endotracheal tube: has NAC caused any change?

Navigating the microbial community in the trachea-oropharynx of breast cancer patients with or without neoadjuvant chemotherapy (NAC) via endotracheal tube: has NAC caused any change?

Journal: PeerJ

Published: April 20, 2023

Dual-energy computed tomography material decomposition improves prediction accuracy of hematoma expansion in traumatic intracranial hemorrhage.

Dual-energy computed tomography material decomposition improves prediction accuracy of hematoma expansion in traumatic intracranial hemorrhage.

Journal: PloS one

Published: August 19, 2022

Development of Entrustable Professional Activity, Core Competencies, and Guidelines in 2021 Radiology Competency Education Project

Development of Entrustable Professional Activity, Core Competencies, and Guidelines in 2021 Radiology Competency Education Project

Journal: Taehan Yongsang Uihakhoe chi

Published: October 13, 2021

Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis.

Hypofractionated Radiotherapy for Early-Stage Breast Cancer: A Propensity Score Matched Analysis.

Journal: Journal of Korean medical science

Published: September 29, 2021

Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge.

Combined treatment with anti-HER2/neu and anti-4-1BB monoclonal antibodies induces a synergistic antitumor effect but requires dose optimization to maintain immune memory for protection from lethal rechallenge.

Journal: Cancer immunology, immunotherapy : CII

Published: May 07, 2021

Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.

Synergism of a novel MCL‑1 downregulator, acriflavine, with navitoclax (ABT‑263) in triple‑negative breast cancer, lung adenocarcinoma and glioblastoma multiforme.

Journal: International journal of oncology

Published: April 29, 2021

Showing 1-12 of 59

Last Updated: 09/26/2026